Correction to: Lung metastasectomy after colorectal cancer: prognostic impact of resection margin on long term survival, a retrospective cohort study.

The original version of this article, unfortunately, contained an error. In Fig. 2 - panel d, incorrect image was published and this is now presented correctly in this article.

Lung metastasectomy after colorectal cancer: prognostic impact of resection margin on long term survival, a retrospective cohort study.

Background: Pulmonary metastasectomy is considered a potentially curative treatment for selected patients with metastatic colorectal cancer (CRC). Several prognostic factors have been analysed, but to date, it is still not well defined which is the optimal resection margin during lung metastasectomy (LM). This study analyses the long-term results and prognostic factors after LM in CRC patients with particular attention to the resection margins.

Minimally invasive mediastinal surgery.

In the past, mediastinal surgery was associated with the necessity of a maximum exposure, which was accomplished through various approaches. In the early 1990s, many surgical fields, including thoracic surgery, observed the development of minimally invasive techniques. These included video-assisted thoracic surgery (VATS), which confers clear advantages over an open approach, such as less trauma, short hospital stay, increased cosmetic results and preservation of lung function.

Robotic lobectomy: tips, pitfalls and troubleshooting.

The robotic approach in thoracic surgery has rapidly gained popularity in recent years. As with the introduction of any new technology, this warrants not only adaptation of the operative technique itself, but also the evolution of appropriate troubleshooting strategies. A selected number of helpful tips and technical procedural manoeuvres have been compiled to prevent intraoperative problems, as well as to overcome challenging situations that can arise during robotic lobectomies.

VATS-based approach for robotic lobectomy.

Lobectomy with systematic lymph node sampling or dissection remains the mainstay of treatment of early stage non-small cell lung cancer. The use of video-assisted thoracic surgery (VATS) to perform lobectomy was first reported in 1992. Advantages of VATS include less trauma and pain, shorter chest drainage duration, decreased hospital stay, and preservation of short-term pulmonary function.

Robotic lobectomy for lung cancer: evolution in technique and technology.

Objectives: The aim of this study was to analyse the results of robotic lobectomy for lung cancer. The evolution of technique and technology was evaluated.

Methods: During the period 2004-12, all patients who underwent robotic lobectomy for clinical early-stage lung cancer were retrospectively reviewed.

Sentinel lymph node in lung cancer surgery.

The greatest utility of sentinel lymph node (SLN) assessment is the avoidance of lymph node dissection and related morbidity. Another potential utility is the ability to direct pathologic examination and more sensitive techniques to detect occult micrometastatic disease. New pathologic methods can identify single tumor cells or even genetic material within a single lymph node station, bringing the concept of ultrastaging and micrometastasis in the field on staging.

Robot-assisted resection of pulmonary sequestrations.

Pulmonary sequestration is a rare congenital malformation and may cause recurrent infections and hemoptysis. Although video-assisted thoracic surgery (VATS) is feasible, some drawbacks remain, mainly dealing the managing of anomalous vessels. We describe the use of a robotic system (da Vinci Robotic System, Surgical Intuitive, Mountain View, CA, USA) in the treatment of four consecutive cases of pulmonary sequestration.

Robotically assisted lobectomy: learning curve and complications.

The past two decades have witnessed a revolutionary transition in surgical technique and technology with the development of minimally invasive approaches. Many advantages were obtained by using video-assisted thoracoscopic surgery: less surgical trauma and pain, shorter hospital stay, and satisfactory cosmetic results. Limitations still remain, however, because of impaired vision, restricted instrument-maneuverability, unstable camera platform, and poor ergonomics for the surgeon.

Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction.

Objective: We previously reported the results achieved in detecting sentinel lymph nodes (SLN). We applied the molecular techniques (RT-PCR) to improve the detection of micrometastasis in order to evaluate an improvement of staging in early non-small cell lung cancer (NSCLC) patients (pts).

Methods: This study was carried out on 22 consecutive NSCLC pts with stage I disease.

Video robotic lobectomy.

Video-assisted thoracoscopic surgery (VATS) is beneficial to the patient but challenging for the surgeon. Recently, robots have been introduced into surgical procedures in an attempt to facilitate surgical performance. The da Vinci™ Robotic System (Intuitive Surgical, Inc, CA, USA) is one of these robots.

Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer.

Objectives: The aim of this study was to determine the accuracy and the role of the sentinel lymph node (SLN) technique in patients with early non-small cell lung cancer (NSCLC).

Methods: This study was carried out on 29 consecutive patients (M/F = 24:5, mean age 65.9 +/- 7.

Early experience with robotic technology for thoracoscopic surgery.

Objective: Recently, robots have been introduced into surgical procedures in an attempt to facilitate surgical performance. The purpose of this study was to develop a technique to perform thoracoscopic lung resection using a telemanipulation system.

Methods: We have used a robotic system to perform thoracoscopic surgery in 12 cases: five lobectomies, three tumor enucleations, three excisions and one bulla stitching completed with fibrin glue for spontaneous pneumothorax.

The management of malignant pericardial effusions using permanently implanted devices.

We present a new approach utilising VATS and a Port-system (Medi-Port MP-GS9; IAP-HMP) that allows home management of pericardial effusion in patients with advanced malignancy and recurrent effusion. All patients underwent thoracoscopic pericardial window under general anaesthesia. On completion of this procedure a Port-system was permanently implanted with the reservoir body placed in a subcutaneous pocket and the outlet catheter inserted into the pleural cavity which allows aspiration of the effusion at home, on becoming symptomatic.